Novartis acquires Synnovation’s breast cancer drug for up to $3 billion
Novartis today announced that it has entered into an agreement with Synnovation Therapeutics, LLC to acquire SNV4818, a…
Novartis’ Bold Move: Acquiring Potential Game-Changer in Breast Cancer Treatment
In a significant move within the pharmaceutical sector, Novartis has struck a deal to acquire SNV4818, a…
Novartis settles with Henrietta Lacks’ estate over use of her ‘stolen’ cells to advance medicine | News
Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited…
Novartis settles with Henrietta Lacks’ estate over use of her cells
Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited…